Dr. Irina Meln is a Senior Innovation Manager at the European Vaccine Initiative (EVI), in Heidelberg, Germany. Irina develops, secures funding, and leads large collaborative projects leveraging public-private partnerships to increase innovations in the vaccine field. Irina has a scientific background with 15+ years of experience in biomedical research and 10+ years in project and alliance management. Irina holds a Ph.D. in Biosciences from the Ruprecht Karls University, Heidelberg. Irina leads Inno4Vac project which aims to accelerate and de-risk vaccine development and PrIMAVeRa project which develops decision-making tools to demonstrate the health and economic value of vaccines to combat antimicrobial resistance (AMR).